title: Implementation of a pharmacy-driven program to improve nasal mupirocin use.
authors.affiliation: Infectious Diseases Clinical Pharmacist, Department of Pharmacy, Cleveland Clinic, OH 44195, USA. neunere@ccf.org
authors.forename: Elizabeth A
authors.initials: EA
authors.lastname: Neuner
authors.forename: Jennifer
authors.initials: J
authors.lastname: Sekeres
authors.forename: Aleksander
authors.initials: A
authors.lastname: Ristich
authors.forename: Jason
authors.initials: J
authors.lastname: Skok
authors.forename: Miriam
authors.initials: M
authors.lastname: Rosenblatt
authors.forename: Cynthia
authors.initials: C
authors.lastname: Fatica
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Fraser
mesh_terms: D000281:Administration, Intranasal; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003428:Cross Infection; D006801:Humans; D008403:Mass Screening / Q000379:methods; D055118:Medication Adherence; D016712:Mupirocin / Q000008:administration & dosage / Q000627:therapeutic use*; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D016712:Mupirocin